Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bone ; 17(4 Suppl): 233S-239S, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8579922

RESUMO

Six-month old rats chronically submitted to right hindlimb immobilization (IM) with mechanical overload (OL) of the left leg were treated 1 month later with 200 micrograms/kg/d of hPTH(1-38) for 15 or 75 days. Peripheral quantitative computed tomography (pQCT) scans and bending tests showed that hPTH increased cortical mass and volumetric BMD (vCtBMD) in both legs. However, elastic modulus of cortical bone and diaphyseal load-bearing capacity were improved only in OL bones. Improvement of diaphyseal strength was attributable to that of cortical bone quality, yet a stronger mechanostatic response of cortical modeling to bone material quality was also observed in treated OL bones. Data support hPTH(1-38) use for improving cortical bone mass and strength and point out a physical activity interaction with therapeutic results.


Assuntos
Fêmur/efeitos dos fármacos , Hormônio Paratireóideo/farmacologia , Fragmentos de Peptídeos/farmacologia , Tomografia Computadorizada por Raios X , Análise de Variância , Animais , Fenômenos Biomecânicos , Feminino , Fêmur/diagnóstico por imagem , Ratos , Ratos Sprague-Dawley , Restrição Física , Fatores de Tempo
2.
Bone ; 17(4 Suppl): 321S-327S, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8579934

RESUMO

An anabolic effect of hPTH(1-38) (s.c. doses of 200 micrograms/kg/d during 75 days) on trabecular and cortical bone mass is tomographically described in the metaphyseal region of immobilized rat femurs using pQCT technology, in agreement with previous histomorphometrical studies of the proximal tibial metaphyses. Correlations between pQCT and histomorphometrical data showed that this effect derived from a stimulation of endosteal and trabecular bone modeling that induced a transference from trabecular to cortical bone mass. Loss of effects after withdrawal, resulting from a stimulation of bone remodeling, could be total or partially prevented by subsequent s.c. injections of risedronate (5 micrograms/kg/2/wk), 17-B-estradiol (10 micrograms/kg/d) or calcitonin (10 micrograms/kg/d) given during 60 days, in this order of effectiveness. The preventive potency was proportionally related to the reduction induced in histomorphometric indices of bone resorption.


Assuntos
Remodelação Óssea/efeitos dos fármacos , Fêmur/efeitos dos fármacos , Hormônio Paratireóideo/uso terapêutico , Fragmentos de Peptídeos/uso terapêutico , Tíbia/efeitos dos fármacos , Tomografia Computadorizada por Raios X , Animais , Esquema de Medicação , Feminino , Fêmur/diagnóstico por imagem , Fêmur/patologia , Ratos , Ratos Sprague-Dawley , Restrição Física , Tíbia/diagnóstico por imagem , Tíbia/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA